Have you seen the headlines about an increased risk of breast cancer associated with levonorgestrel IUDs? You might know these IUDs as Mirena, Kyleena, Skyla, or Liletta. Before you head to your OBGYN to schedule a removal, hang on: there's so much more to the story than just the headline. Lucky for us, our Docs, Dr. Amy Voedisch and Dr. Rebecca Dunsmoor-Su, have dedicated this episode of OvaryActive to breaking down the science and the stats surrounding breast cancer, the role of progestins, and the implications of recent studies. What are the benefits, risks, truths, and misconceptions around birth control, including IUDs? In this episode, our Docs define the hormone lingo, explain what the Swedish study actually means, and clear up the difference between "absolute" risk and "relative" risk. You will walk away with a much better understanding of what questions to ask your doctor about using an IUD or other birth control during perimenopause. This discussion is a great reminder to dig deeper when you see those scary headlines. Media representation of women's health often lacks nuance, which is why OvaryActive is here for you! And don't forget to share this episode with a friend, sister, or colleague who may benefit from learning more. What you'll hear in this episode: [0:30] IUDs & breast cancer [3:55] Progestins (different than progesterone) [10:13] Let's talk about the Swedish study [21:52] Uterine cancer & IUDs (it's good news) [25:42] Other recent studies on IUDs [31:21] IUDs in perimenopause [37:59] Addressing misconceptions and media representation Follow the show @OvaryActive Instagram | YouTube Meet the Docs: More information about Dr. Rebecca Dunsmoor-Su: Gennev: www.gennev.com/clinician/dr-rebecca-dunsmoor-su LinkedIn @rebecca-dunsmoor-su More information about Dr. Amy Voedisch: Stanford Medical Clinic: stanfordhealthcare.org/doctors/v/amy-voedisch.html

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related